Which medicine works best for Covid-19 treatment? WHO answers

Healthcare experts around the world tout vaccinations and adherence to Covid-appropriate behavior to be paramount to the fight against the coronavirus.

For those infected, it is equally important to know your best treatment options -- the right medicines and drugs that have been effective in reducing mortality, hospitalisation, and ventilation.

As per the World Health Organisation (WHO), Baricitinib, Ruxolitinib, tofacitinib, Sotrovimab, Casirivimab-imdevimab, Tocilizumab or sarilumab can be used for Covid-19 treatment.

While Baricitinib, Tocilizumab or sarilumab are highly recommended for treatment, Ruxolitinib and tofacitinib, Sotrovimab, Casirivimab-imdevimab are usually given either as a substitute or only under certain circumstances.

Meanwhile, the use of Ivermectin, Hydroxychloroquine, Lopinavir/ritonavir, and Remdesivir is not currently recommended due to a lack of proof for their usage being beneficial or the medicines still being under clinical trials.

For children, so far the use of casirivimab and imdevimab have been recommended, as per the WHO. Tocilizumab is also recommended for kids.

Very few children have become critically ill with Covid-19, but severe symptoms like chest pains can occur.

However, as previously mentioned, vaccination still remains our best weapon against the coronavirus.

"Vaccination is having a substantial impact on case numbers and hospitalizations in a number of high-income countries, but limitations in global access to vaccines mean that many populations remain vulnerable," the WHO says.